INSIGHTS & STRATEGIES > ARTICLES
WisdomTree Insights
Dr Jamie Metzl, with whom we work on our Biorevolution strategy, recently published Superconvergence: How the Genetics, Biotech, and AI Revolutions will Transform our Lives, Work and World. We believe we are on the precipice of a remarkable period in this field, which will evolve how we do things. Here, we discuss the topic of possible blockbuster gene therapies, seen through the lens of a specific approach from Sarepta Pharmaceuticals to treat Duchenne Muscular Dystrophy.
Read the article
Dr Jamie Metzl, with whom we work on our Biorevolution strategy, recently published Superconvergence: How the Genetics, Biotech, and AI Revolutions will Transform our Lives, Work and World. We believe we are on the precipice of a remarkable period in this field, which will evolve how we do things. Here, we discuss the topic of possible blockbuster gene therapies, seen through the lens of a specific approach from Sarepta Pharmaceuticals to treat Duchenne Muscular Dystrophy.
Read the article
Dr Jamie Metzl, with whom we work on our Biorevolution strategy, recently published Superconvergence: How the Genetics, Biotech, and AI Revolutions will Transform our Lives, Work and World. We believe we are on the precipice of a remarkable period in this field, which will evolve how we do things. Here, we discuss the topic of CAR-T therapies, which, similar to mRNA, could represent a platform upon which many interesting therapies may be built.
Read the article
Dr Jamie Metzl, with whom we work on our Biorevolution strategy, recently published Superconvergence: How the Genetics, Biotech, and AI Revolutions will Transform our Lives, Work and World. We believe we are on the precipice of a remarkable period in this field, which will evolve how we do things. Here, we discuss how generative AI is leading us on an exciting path toward being able to simulate chemical interactions within cells.
Read the article
Dr Jamie Metzl, with whom we work on our Biorevolution strategy, recently published Superconvergence: How the Genetics, Biotech, and AI Revolutions will Transform our Lives, Work and World. In this blog, we discuss the self-driving lab, an example of the convergence of biotechnology and AI.
Read the article
Dr Jamie Metzl, with whom we work on our Biorevolution strategy, recently published Superconvergence: How the Genetics, Biotech, and AI Revolutions will Transform our Lives, Work and World. We believe we are on the precipice of a remarkable period in this field, which will evolve how we do things. Here, we discuss the topic of mRNA, something that got a lot of attention during the COVID-19 pandemic.
Read the article
Google DeepMind and Isomorphic Labs unveiled AlphaFold 3, an AI-powered tool that will revolutionise the discovery of new drugs. With AI poised to transform biotechnology, this could be the first of many breakthroughs in this sector. Given the underappreciation in markets of the potential growth in this space, there may be an exciting opportunity here for thematic investors seeking long-term opportunities.
Read the article